← Back to Search

Robotic Device

NeuroExo for Hemiparesis (NeuroExo Trial)

N/A
Recruiting
Led By Gerard Francisco, MD
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately after end of treatment (within a week), and 4 weeks after end of treatment
Awards & highlights

NeuroExo Trial Summary

The goal of this study is to develop a clinically feasible, low-cost, nonsurgical neurorobotic system for restoring function to motor-impaired stroke survivors that can be used at the clinic or at home. Moreover, another goal is to understand how physical rehabilitation assisted by robotic device combined with electroencephalograph (EEG) can benefit adults who have had stroke to improve functions of their weaker arm. The proposed smart co-robot training system (NeuroExo) is based on a physical upper-limb robotic exoskeleton commanded by a non-invasive brain machine interface (BMI) based on scalp EEG to actively include the participant in the control loop . The study will demonstrate that the Neuroexo smart co-robot arm training system is feasible and effective in improving arm motor functions in the stroke population for their use at home.The NeuroExo study holds the promise to be cost-effective patient-centered neurorehabilitation system for improving arm functions after stroke.

Eligible Conditions
  • Hemiparesis
  • Stroke

NeuroExo Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately after end of treatment (within a week), and 4 weeks after end of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after end of treatment (within a week), and 4 weeks after end of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline in Fugl-Meyer Arm (FMA) Motor Score
Cortical Dynamics Measured by Electroencephalography (EEG) Movement-related Cortical Potential (MRCP) Latency
Movement Quality as Assessed by Exoskeleton Kinematics
+3 more
Secondary outcome measures
Grip Strength
Pinch Strength
Score on Action Research Arm Test (ARAT)
+1 more

NeuroExo Trial Design

1Treatment groups
Experimental Treatment
Group I: NeuroExoExperimental Treatment1 Intervention
NeuroExo is a device which includes a robotic exoskeleton that you were in your affected arm to assist you with arm movements, a headset that you wear on your head to measure your brain activity and detect your intention to move, and a graphical user interface that allows you to initiate and stop neurotherapy, and track your motor performance.

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor
147 Previous Clinical Trials
47,522 Total Patients Enrolled
2 Trials studying Hemiparesis
78 Patients Enrolled for Hemiparesis
TIRR Memorial HermannOTHER
15 Previous Clinical Trials
4,725 Total Patients Enrolled
3 Trials studying Hemiparesis
118 Patients Enrolled for Hemiparesis
The University of Texas Health Science Center, HoustonOTHER
903 Previous Clinical Trials
320,994 Total Patients Enrolled
2 Trials studying Hemiparesis
78 Patients Enrolled for Hemiparesis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025